Hypopigmentation

Last updated
Hypopigmentation
Vitiligo03.jpg
Hypopigmentation in vitiligo
Specialty Dermatology   OOjs UI icon edit-ltr-progressive.svg

Hypopigmentation is characterized specifically as an area of skin becoming lighter than the baseline skin color, but not completely devoid of pigment. This is not to be confused with depigmentation, which is characterized as the absence of all pigment. [1] It is caused by melanocyte or melanin depletion, or a decrease in the amino acid tyrosine, which is used by melanocytes to make melanin. [2] Some common genetic causes include mutations in the tyrosinase gene or OCA2 gene. [3] [4] As melanin pigments tend to be in the skin, eye, and hair, these are the commonly affected areas in those with hypopigmentation. [2]

Contents

Hypopigmentation is common and approximately one in twenty have at least one hypopigmented macule. Hypopigmentation can be upsetting to some, especially those with darker skin whose hypopigmentation marks are seen more visibly. Most causes of hypopigmentation are not serious and can be easily treated. [5]

Presentation

Associated conditions

It is seen in:

Diagnosis

Areas of lighter pigmentation can be indications of hypopigmentation. Biopsies and genetic information are also used to diagnose.

Treatments

Often, hypopigmentation can be brought on by laser treatments; however, the hypopigmentation can be treated with other lasers or light sources. [6] Micropigmentation can also be used to obtain a more normal appearance of the hypopigmentated skin. [7]

Treatment for hypopigmentation depends on the initial cause of the discoloration.[ medical citation needed ]

Treatments for Hypopigmentation [8]
Initial Cause of DiscolorationTreatment
Idiopathic guttate hypomelanosis No treatment
Postinflammatory hypopigmentation Treat the underlying inflammatory disease to restore pigmentation
Pityriasis versicolor A topical ointment, such as selenium sulfide 2.5% or imidazoles.

Can also use oral medications, such as oral imidazoles or triazoles.

Vitiligo Topical steroids, including calcineurin inhibitors.

Patients can also have transplants if they are stable or a depigmentation with topical MBEH if the patient has widespread discoloration.

Chemical or drug induced leukoderma Avoidance of causative agent with subsequent treatment similar to vitiligo.
Piebaldism None; occasionally transplants.

See also

Related Research Articles

<span class="mw-page-title-main">Melanin</span> Group of natural pigments found in most organisms

Melanin is a family of biomolecules organized as oligomers or polymers, which among other functions provide the pigments of many organisms. Melanin pigments are produced in a specialized group of cells known as melanocytes.

<span class="mw-page-title-main">Melanocytic nevus</span> Benign skin tumor of pigment-producing cells

A melanocytic nevus is usually a noncancerous condition of pigment-producing skin cells. It is a type of melanocytic tumor that contains nevus cells. A mole can be either subdermal or a pigmented growth on the skin, formed mostly of a type of cell known as a melanocyte. The high concentration of the body's pigmenting agent, melanin, is responsible for their dark color. Moles are a member of the family of skin lesions known as nevi, occurring commonly in humans. Some sources equate the term "mole" with "melanocytic nevus", but there are also sources that equate the term "mole" with any nevus form.

<span class="mw-page-title-main">Vitiligo</span> Skin condition where patches lose pigment

Vitiligo is a chronic autoimmune disorder that causes patches of skin to lose pigment or color. The cause of vitiligo is unknown, but it may be related to immune system changes, genetic factors, stress, or sun exposure. Treatment options include topical medications, light therapy, surgery and cosmetics. The condition can show up on any skin type as a light peachy color and can appear on any place on the body in all sizes. The spots on the skin known as vitiligo are also able to “change” as spots lose and regain pigment; they will stay in relatively the same areas but can move over time and some big patches can move through the years but never disappear overnight.

The melanocyte-stimulating hormones, known collectively as MSH, also known as melanotropins or intermedins, are a family of peptide hormones and neuropeptides consisting of α-melanocyte-stimulating hormone (α-MSH), β-melanocyte-stimulating hormone (β-MSH), and γ-melanocyte-stimulating hormone (γ-MSH) that are produced by cells in the pars intermedia of the anterior lobe of the pituitary gland.

<span class="mw-page-title-main">Heterochromia iridum</span> Difference in coloration, usually of the iris but also of hair or skin

Heterochromia is a variation in coloration most often used to describe color differences of the iris, but can also be applied to color variation of hair or skin. Heterochromia is determined by the production, delivery, and concentration of melanin. It may be inherited, or caused by genetic mosaicism, chimerism, disease, or injury. It occurs in humans and certain breeds of domesticated animals.

<span class="mw-page-title-main">Nevus</span> Mole or birthmark; visible, circumscribed, chronic skin lesion

Nevus is a nonspecific medical term for a visible, circumscribed, chronic lesion of the skin or mucosa. The term originates from nævus, which is Latin for "birthmark"; however, a nevus can be either congenital or acquired. Common terms, including mole, birthmark, and beauty mark, are used to describe nevi, but these terms do not distinguish specific types of nevi from one another.

<span class="mw-page-title-main">Hyperpigmentation</span> Darkening of an area of skin or nails due to increased melanin

Hyperpigmentation is the darkening of an area of skin or nails caused by increased melanin.

<span class="mw-page-title-main">Café au lait spot</span> Type of birthmark caused by a collection of melanocytes

Café au lait spots, or café au lait macules, are flat, hyperpigmented birthmarks. The name café au lait is French for "coffee with milk" and refers to their light-brown color. They are caused by a collection of pigment-producing melanocytes in the epidermis of the skin. These spots are typically permanent and may grow or increase in number over time.

<span class="mw-page-title-main">Melasma</span> Medical condition

Melasma is a tan or dark skin discoloration. Melasma is thought to be caused by sun exposure, genetic predisposition, hormone changes, and skin irritation. Although it can affect anyone, it is particularly common in women, especially pregnant women and those who are taking oral or patch contraceptives or hormone replacement therapy medications.

<span class="mw-page-title-main">Skin whitening</span> Practice of using chemical substances to lighten the skin

Skin whitening, also known as skin lightening and skin bleaching, is the practice of using chemical substances in an attempt to lighten the skin or provide an even skin color by reducing the melanin concentration in the skin. Several chemicals have been shown to be effective in skin whitening, while some have proven to be toxic or have questionable safety profiles. This includes mercury compounds which may cause neurological problems and kidney problems.

<span class="mw-page-title-main">Griscelli syndrome</span> Medical condition

Griscelli syndrome is a rare autosomal recessive disorder characterized by albinism (hypopigmentation) with immunodeficiency, that usually causes death by early childhood. Researchers have developed three different classifications of the form of disorder, characterised by different signs and symptoms. Type 1 Griscelli Syndrome is associated with severe brain function issues along with distinctive discolouring of the hair and skin. Type 2 Griscelli Syndrome have immune system abnormalities in addition to hypopigmentation of skin and hair. Finally, Type 3 is seen as those only affected by hypopigmentation of the skin and hair. This type is not associated with immune deficiencies or neurological abnormalities.

<span class="mw-page-title-main">Tattoo removal</span> Dermatologic procedure to remove tattoo pigments

Tattoo removal is the process of removing an unwanted tattoo. The process of tattooing generally creates permanent markings in the skin, but people have attempted many methods to try to hide or destroy tattoos.

<span class="mw-page-title-main">Greying of hair</span> The natural process of hair turning grey or white with age

Greying of hair, also known as greying, canities, or achromotrichia, is the progressive loss of pigmentation in the hair, eventually turning the hair grey or white which typically occurs naturally as people age.

Gum depigmentation, also known as gum bleaching, is a procedure used in cosmetic dentistry to lighten or remove black spots or patches on the gums consisting of melanin. Melanin in skin is very common in inhabitants in many parts of the world due to genetic factors. Melanin pigmentation in skin, oral mucosa, inner ear and other organs is a detoxification mechanism. Some toxic agents bind to melanin and will move out of the tissue with the ageing cells and are expelled to the tissue surfaces. Also in the gums and oral mucosa a visible pigmentation is most often caused by genetic factors, but also by tobacco smoking or in a few cases by long-term use of certain medications. If stopping smoking or change of medication do not solve the problem with a disfigurating melanin pigmentation, a surgical operation may be performed. The procedure itself can involve laser ablation techniques.

Pigmentation disorders are disturbances of human skin color. There may be a loss or reduction, which may be related to loss of melanocytes or the inability of melanocytes to produce melanin or transport melanosomes correctly.

Oculocutaneous albinism type I or type 1A is form of the autosomal recessive condition oculocutaneous albinism that is caused by a dysfunction in the gene for tyrosinase.

Melanonychia is a black or brown pigmentation of a nail, and may be present as a normal finding on many digits in Afro-Caribbeans, as a result of trauma, systemic disease, or medications, or as a postinflammatory event from such localized events as lichen planus or fixed drug eruption.

Postinflammatory hypopigmentation is a cutaneous condition characterized by decreased pigment in the skin following inflammation of the skin.

Oral pigmentation is asymptomatic and does not usually cause any alteration to the texture or thickness of the affected area. The colour can be uniform or speckled and can appear solitary or as multiple lesions. Depending on the site, depth, and quantity of pigment, the appearance can vary considerably.

Postinflammatory hyperpigmentation (PIH) is a skin condition characterized by the darkening of the skin (hyperpigmentation) following an inflammatory injury, such as acne, dermatitis, infectious disease, or trauma. Less frequently, it may occur as a complication of a medical procedure performed on the skin. It is a common cause of skin discoloration and can affect individuals of all skin types.

References

  1. 1 2 Shinkai, Kanade; Fox, Lindy (2018). "Dermatological Disorders". Current Medical Diagnosis & Treatment. New York, NY: McGraw-Hill.
  2. 1 2 3 4 Ferrier, Denise R. (2017). Biochemistry (Seventh ed.). Philadelphia. ISBN   978-1-4963-4449-6. OCLC   956263971.{{cite book}}: CS1 maint: location missing publisher (link)
  3. Bolognia, Jean; Braverman, Irwin (2014). "Skin Manifestations of Internal Disease". Harrison's Principles of Internal Medicine. New York, NY: McGraw-Hill.
  4. Cross, Harold. "Biochemical Basis of Diseases". The Big Picture: Medical Biochemistry Eds. New York, NY: McGraw-Hill.
  5. Hill, Jeremy P.; Batchelor, Jonathan M. (2017-01-12). "An approach to hypopigmentation". BMJ. 356: i6534. doi:10.1136/bmj.i6534. ISSN   0959-8138. PMID   28082370. S2CID   26827617.
  6. Reszko, Anetta; Sukal, Sean A.; Geronemus, Roy G. (14 July 2008). "Reversal of Laser-Induced Hypopigmentation with a Narrow-Band UV-B Light Source in a Patient with Skin Type VI". Dermatologic Surgery. 34 (10): 1423–1426. doi:10.1097/00042728-200810000-00021. PMID   18637814.
  7. Haney, Beth (September 21, 2019). "Permanent and Semi-permanent Micro-Pigment Treatments". Aesthetic Procedures: Nurse Practitioner's Guide to Cosmetic Dermatology. Cham: Springer International Publishing. pp. 59–66. doi:10.1007/978-3-030-19948-7_7. ISBN   978-3-030-19947-0. S2CID   203829421.
  8. Harrison's Principles of Internal Medicine. Longo, Dan L. (Dan Louis), 1949-, Fauci, Anthony S., 1940-, Kasper, Dennis L., Hauser, Stephen L., Jameson, J. Larry., Loscalzo, Joseph. (18th ed.). New York: McGraw-Hill. 2012. ISBN   9780071748902. OCLC   747712285.{{cite book}}: CS1 maint: others (link)